Pulmonary metastases in urogenital cancers; surgical treatment and outcomes

Abstract

Background Metastasis is remaining one of the major problems in cancer treatment. Like many other malignancies, urogenital tumors originating from kidney, prostate, testes, and bladder tend to metastasize to the lungs. The aim of this retrospective study is to evaluate the results of pulmonary metastasectomy in patients with primary urogenital tumors. Methods This study was approved by the local ethical committee. This study retrospectively analyses the patients who underwent lung resections for metastases in our department between 2002 and 2018. 22 out of 126 patients referred for pulmonary metastasectomy to our department had metastases from urogenital tumors. or retroperitoneum was described as a negative predictive factor of disease-free survival. ** The number of cases undergoing pulmonary metastasectomy for prostate cancer is very limited in the literature therefore, we reviewed 2 well written case report. *** 6 months survival was reported as 100% for urologic cancers and 94.44% for genital cancers.